Company / Free Cash Flow
NEUROONE MEDICAL TECHNOLOGIES Corp Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$11.1M
FY2025
5-year range
-$13.3M / -$3.5M
FY2021-FY2025
Trend
+16.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 5 years, ranging from -$13M in FY2024 to -$4M in FY2021.
Based on SEC 10-K filings.
-$11M in FY2025.
Declined from -$8M to -$11M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 16.1% year-over-year.
- Peak free cash flow was recorded in FY2021.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.1M | +16.1% |
| FY2024 | -$13.3M | -70.3% |
| FY2023 | -$7.8M | +10.1% |
| FY2022 | -$8.7M | -144.4% |
| FY2021 | -$3.5M | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026